Teratogenic Mechanisms Associated with Prenatal Medication Exposure

被引:12
|
作者
van Gelder, Marleen M. H. J. [1 ]
van Rooijl, Iris A. L. M. [1 ]
de Jong-van den Berg, Lolkje T. W. [2 ]
Roeleveld, Nel [1 ,3 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, NL-6500 HB Nijmegen, Netherlands
[2] Univ Groningen, SHARE, Dept Pharmacoepidemiol & Pharmacoecon, Groningen, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, NL-6500 HB Nijmegen, Netherlands
来源
THERAPIE | 2014年 / 69卷 / 01期
关键词
congenital abnormalities; pharmaceutical agents; pregnancy; teratology; NEURAL-TUBE DEFECTS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HISTONE-DEACETYLASE INHIBITORS; SEROTONIN-REUPTAKE INHIBITORS; FOLIC-ACID ANTAGONISTS; PROSTAGLANDIN-H SYNTHASE; CULTURED RAT EMBRYOS; METHYL-D-ASPARTATE; OXIDATIVE STRESS; RETINOIC ACID;
D O I
10.2515/therapie/2014003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Birth defects may originate through multiple mechanisms and may be caused by a variety of possible exposures, including medications in early pregnancy. In this review, we describe six principal teratogenic mechanisms suspected to be associated with medication use: folate antagonism, neural crest cell disruption, endocrine disruption, oxidative stress, vascular disruption, and specific receptor-or enzyme-mediated teratogenesis. Knowledge about these mechanisms, for some of which evidence is mainly derived from animal models, may not only be relevant for etiologic and post-marketing research, but may also have implications for prescribing behavior for women of reproductive age. Since combinations of seemingly unrelated medications may have effects through similar teratogenic mechanisms, the risk of birth defects may be strongly increased in multi-therapy.
引用
收藏
页码:13 / 24
页数:12
相关论文
共 50 条
  • [1] PRENATAL ETHANOL EXPOSURE IN MICE - TERATOGENIC EFFECTS
    RANDALL, CL
    TAYLOR, WJ
    TERATOLOGY, 1979, 19 (03) : 305 - 311
  • [2] Prenatal Care Initiation and Exposure to Teratogenic Medications
    Winterstein, Almut G.
    Wang, Yanning
    Smolinski, Nicole E.
    Thai, Thuy N.
    Ewig, Celeste
    Rasmussen, Sonja A.
    JAMA NETWORK OPEN, 2024, 7 (02)
  • [3] PRENATAL EXPOSURE TO TERATOGENIC AGENTS AND NEURODEVELOPMENTAL OUTCOME
    ADAMS, J
    RESEARCH IN INFANT ASSESSMENT, 1989, 25 : 63 - 72
  • [4] Prenatal anticonvulsant drug exposure: Teratogenic effect on the dentition
    Orup, HI
    Keith, DA
    Holmes, LB
    JOURNAL OF CRANIOFACIAL GENETICS AND DEVELOPMENTAL BIOLOGY, 1998, 18 (03): : 129 - 137
  • [5] PRENATAL EXPOSURE TO DIAZEPAM - LATE POSTNATAL TERATOGENIC EFFECT
    LIVEZEY, GT
    MARCZYNSKI, TJ
    MCGREW, EA
    BELUHAN, FZ
    NEUROBEHAVIORAL TOXICOLOGY AND TERATOLOGY, 1986, 8 (05): : 433 - 440
  • [6] Teratogenic Effects of Prenatal Alcohol Exposure on Cardiac Innervation
    Conlon, Steven
    PEDIATRICS, 2021, 147 (03)
  • [7] NEURO-BEHAVIORAL TERATOGENIC EFFECTS OF PRENATAL EXPOSURE TO COCAINE
    SPEAR, LP
    FRAMBES, N
    KIRSTEIN, CL
    BELL, J
    ROGERS, L
    YOOTTANASUMPUN, V
    SPEAR, NE
    TERATOLOGY, 1988, 37 (05) : 517 - 518
  • [8] Is polypharmacy associated with transient neonatal symptoms following prenatal psychotropic medication exposure?
    Oberlander, TF
    Misri, S
    Fitzgerald, CE
    Kostaras, X
    Rurak, D
    Riggs, W
    PEDIATRIC RESEARCH, 2003, 53 (04) : 426A - 426A
  • [9] Neurodevelopment after prenatal exposure to antidepressant medication
    Pedersen, L. H.
    Henriksen, T. B.
    Olsen, J.
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2007, 79 (05) : 359 - 359
  • [10] Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure
    Oberlander, TF
    Misri, S
    Fitzgerald, CE
    Kostaras, X
    Rurak, D
    Riggs, W
    JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (02) : 230 - 237